학술논문
Durability of ChAdOx1 nCoV-19 (AZD1222) vaccine and hybrid humoral immunity against variants including omicron BA.1 and BA.4 6 months after vaccination (COV005): a post-hoc analysis of a randomised, phase 1b–2a trial
Document Type
Article
Author
Madhi, Shabir A ; Kwatra, Gaurav; Richardson, Simone I; Koen, Anthonet L; Baillie, Vicky; Cutland, Clare L; Fairlie, Lee; Padayachee, Sherman D; Dheda, Keertan; Barnabas, Shaun L; Bhorat, Qasim Ebrahim; Briner, Carmen; Ahmed, Khatija; Aley, Parvinder K; Bhikha, Sutika; Bhorat, A E; Esmail, Aliasgar; Horne, Elizea; Kaldine, Haajira; Mukendi, Christian K; Madzorera, Vimbai Sharon; Manamela, Nelia P; Masilela, Mduduzi; Hermanus, S Tandile; Motlou, Thopisang; Mzindle, Nonkululeko; Oelofse, Suzette; Patel, Faeezah; Rhead, Sarah; Rossouw, Lindie; Taoushanis, Carol; van Eck, Samuel; Lambe, Teresa; Gilbert, Sarah C; Pollard, Andrew J; Moore, Penny L; Izu, Alane
Source
In The Lancet Infectious Diseases March 2023 23(3):295-306
Subject
Language
ISSN
1473-3099